Table of Contents

- M Gerritsen
Problems associated with subcutaneously implanted glucose sensors.
Diabetes Care February 2000 23:143-145; doi:10.2337/diacare.23.2.143
- Full Text (PDF)
- D Marrero and
- S Edelman
Hypoglycemia and driving performance: a flashing yellow light?
Diabetes Care February 2000 23:146-147; doi:10.2337/diacare.23.2.146
- Full Text (PDF)
- B M Frier
Hypoglycemia and driving performance.
Diabetes Care February 2000 23:148-150; doi:10.2337/diacare.23.2.148
- Full Text (PDF)
- G S Eisenbarth
Isotypes of anti-islet autoantibodies.
Diabetes Care February 2000 23:151-152; doi:10.2337/diacare.23.2.151
- Full Text (PDF)
Select this article
- D Simmons,
- M Upjohn,
- and G D Gamble
Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial.
Diabetes Care February 2000 23:153-156; doi:10.2337/diacare.23.2.153
- Abstract
- Full Text (PDF)
Select this article
- T R Pieber,
- I Eugène-Jolchine,
- and E Derobert
Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.
Diabetes Care February 2000 23:157-162; doi:10.2337/diacare.23.2.157
- Abstract
- Full Text (PDF)
Select this article
- D J Cox,
- L A Gonder-Frederick,
- B P Kovatchev,
- D M Julian,
- and W L Clarke
Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction.
Diabetes Care February 2000 23:163-170; doi:10.2337/diacare.23.2.163
- Abstract
- Full Text (PDF)
Select this article
- H Yeni-Komshian,
- M Carantoni,
- F Abbasi,
- and G M Reaven
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.
Diabetes Care February 2000 23:171-175; doi:10.2337/diacare.23.2.171
- Abstract
- Full Text (PDF)
Select this article
- H E Resnick,
- M I Harris,
- D B Brock,
- and T B Harris
American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.
Diabetes Care February 2000 23:176-180; doi:10.2337/diacare.23.2.176
- Abstract
- Full Text (PDF)
Select this article
- E T Lee,
- B V Howard,
- O Go,
- P J Savage,
- R R Fabsitz,
- D C Robbins,
- and T K Welty
Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study.
Diabetes Care February 2000 23:181-186; doi:10.2337/diacare.23.2.181
- Abstract
- Full Text (PDF)
Select this article
- C L Rohlfing,
- R R Little,
- H M Wiedmeyer,
- J D England,
- R Madsen,
- M I Harris,
- K M Flegal,
- M S Eberhardt,
- and D E Goldstein
Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.
Diabetes Care February 2000 23:187-191; doi:10.2337/diacare.23.2.187
- Abstract
- Full Text (PDF)
Select this article
- D B Petitti,
- R Contreras,
- F H Ziel,
- J Dudl,
- E S Domurat,
- and J A Hyatt
Evaluation of the effect of performance monitoring and feedback on care process, utilization, and outcome.
Diabetes Care February 2000 23:192-196; doi:10.2337/diacare.23.2.192
- Abstract
- Full Text (PDF)
Select this article
- J M Mooy,
- H de Vries,
- P A Grootenhuis,
- L M Bouter,
- and R J Heine
Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn Study.
Diabetes Care February 2000 23:197-201; doi:10.2337/diacare.23.2.197
- Abstract
- Full Text (PDF)
Select this article
- M Hanefeld,
- K P Bouter,
- S Dickinson,
- and C Guitard
Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.
Diabetes Care February 2000 23:202-207; doi:10.2337/diacare.23.2.202
- Abstract
- Full Text (PDF)
Select this article
- S J Updike,
- M C Shults,
- B J Gilligan,
- and R K Rhodes
A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration.
Diabetes Care February 2000 23:208-214; doi:10.2337/diacare.23.2.208
- Abstract
- Full Text (PDF)
Select this article
- F Khan,
- T A Elhadd,
- S A Greene,
- and J J Belch
Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes.
Diabetes Care February 2000 23:215-220; doi:10.2337/diacare.23.2.215
- Abstract
- Full Text (PDF)
Select this article
- S C Elbein,
- K Wegner,
- and S E Kahn
Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
Diabetes Care February 2000 23:221-227; doi:10.2337/diacare.23.2.221
- Abstract
- Full Text (PDF)
Select this article
- M I Hawa,
- D Fava,
- F Medici,
- Y J Deng,
- A L Notkins,
- G De Mattia,
- and R D Leslie
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
Diabetes Care February 2000 23:228-233; doi:10.2337/diacare.23.2.228
- Abstract
- Full Text (PDF)
Select this article
- M E Hartnett,
- R D Stratton,
- R W Browne,
- B A Rosner,
- R J Lanham,
- and D Armstrong
Serum markers of oxidative stress and severity of diabetic retinopathy.
Diabetes Care February 2000 23:234-240; doi:10.2337/diacare.23.2.234
- Abstract
- Full Text (PDF)
Select this article
- E A Whitsel,
- E J Boyko,
- and D S Siscovick
Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis.
Diabetes Care February 2000 23:241-247; doi:10.2337/diacare.23.2.241
- Abstract
- Full Text (PDF)
- Z T Bloomgarden
American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes.
Diabetes Care February 2000 23:248-252; doi:10.2337/diacare.23.2.248
- Full Text (PDF)
- H Kinoshita,
- K Kato,
- M Kuroki,
- S Nakamura,
- K Kitamura,
- S Hisanaga,
- S Fujimoto,
- and T Eto
Plasma adrenomedullin levels in patients with diabetes.
Diabetes Care February 2000 23:253-254; doi:10.2337/diacare.23.2.253
- Full Text (PDF)
- Y Wen,
- A Sahni,
- C A Rea,
- X H Zhang,
- M A Khokher,
- and B M Singh
Differential antioxidant status among Indo-Asians compared with caucasians with and without diabetes. Wolverhampton Diabetes Research Group.
Diabetes Care February 2000 23:254-255; doi:10.2337/diacare.23.2.254
- Full Text (PDF)
- S A Aldasouqi and
- W J Logue
The Batista procedure significantly improved cardiac function and glycemic control in a diabetic patient with severe insulin resistance.
Diabetes Care February 2000 23:255-256; doi:10.2337/diacare.23.2.255
- Full Text (PDF)
- N Yabunaka,
- J Nishihira,
- Y Mizue,
- M Tsuji,
- M Kumagai,
- Y Ohtsuka,
- M Imamura,
- and M Asaka
Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.
Diabetes Care February 2000 23:256-258; doi:10.2337/diacare.23.2.256
- Full Text (PDF)
- R A Hegele,
- C M Anderson,
- and H Cao
Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance.
Diabetes Care February 2000 23:258-259; doi:10.2337/diacare.23.2.258
- Full Text (PDF)
- M Fukushima,
- A Taniguchi,
- M Sakai,
- K Doi,
- I Nagata,
- S Nagasaka,
- K Tokuyama,
- and Y Nakai
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
Diabetes Care February 2000 23:259; doi:10.2337/diacare.23.2.259
- Full Text (PDF)
- E Noiri,
- J Taguchi,
- A Nakao,
- and T Fujita
MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.
Diabetes Care February 2000 23:260; doi:10.2337/diacare.23.2.260b
- Full Text (PDF)
- S R Kim,
- E A Talbott,
- E Tull,
- M Vogt,
- S J Andersen,
- and L H Kuller
Contribution of abnormalities of thyroid hormones to type 2 diabetes.
Diabetes Care February 2000 23:260-261; doi:10.2337/diacare.23.2.260a
- Full Text (PDF)

Diabetes Care

Problems associated with subcutaneously implanted glucose sensors.

Hypoglycemia and driving performance: a flashing yellow light?

Hypoglycemia and driving performance.

Isotypes of anti-islet autoantibodies.

Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial.

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.

Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction.

Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.

American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study.

Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.

Evaluation of the effect of performance monitoring and feedback on care process, utilization, and outcome.

Major stressful life events in relation to prevalence of undetected type 2 diabetes: the Hoorn Study.

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration.

Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes.

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.

Serum markers of oxidative stress and severity of diabetic retinopathy.

Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis.

American Diabetes Association Annual Meeting, 1999: insulin action and the development of type 2 diabetes.

Plasma adrenomedullin levels in patients with diabetes.

Differential antioxidant status among Indo-Asians compared with caucasians with and without diabetes. Wolverhampton Diabetes Research Group.

The Batista procedure significantly improved cardiac function and glycemic control in a diabetic patient with severe insulin resistance.

Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.

Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance.

Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.

MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients.

Contribution of abnormalities of thyroid hormones to type 2 diabetes.

This Issue

Current Issue

From the Cover